Condition
Dissection of Thoracic Aorta
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03322033Not ApplicableTerminatedPrimary
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
NCT05639569Recruiting
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
NCT05030740Completed
French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft
NCT02190487CompletedPrimary
Incidence and Risk Factors of Acute Kidney Injury After Thoracic Aortic Surgery Due to Dissection
NCT01369732Phase 4CompletedPrimary
Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
Showing all 5 trials